Low serum IGF-I/GH ratio is associated with abnormal glucose tolerance in acromegaly

被引:10
|
作者
Fukuoka, Hidenori [1 ]
Takahashi, Yutaka [1 ]
Iida, Keiji [1 ]
Kudo, Takumi [1 ]
Nishizawa, Hitoshi [1 ]
Imanaka, Mari [1 ]
Takeno, Ryoko [1 ]
Iguchi, Genzo [1 ]
Takahashi, Kentaro [1 ]
Okimura, Yasuhiko [2 ]
Kaji, Hidesuke [3 ]
Chihara, Kazuo [1 ]
机构
[1] Kobe Univ, Grad Sch Med, Dept Clin Mol Med, Div Endocrinol Metab Nutr & Hematol Oncol,Chuo Ku, Kobe, Hyogo 6500017, Japan
[2] Kobe Univ, Sch Med, Dept Basic Allied Med, Kobe, Hyogo, Japan
[3] Univ Hyogo, Div Physiol Metabol, Kobe, Hyogo, Japan
关键词
acromegaly; growth hormone; insulin-like growth factor-I; glucose tolerance; diabetes mellitus;
D O I
10.1159/000112590
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: Acromegaly is frequently accompanied with impaired glucose tolerance (IGT) and diabetes mellitus ( DM). It remains unclear which factors determine the abnormal glucose tolerance status in acromegaly. In addition, diverse actions of GH and IGF-I in regulating glucose metabolism in acromegaly have not yet been well elucidated. The aim of this study was to investigate the factors associated with abnormal glucose tolerance in acromegaly. Subjects and Study Design: We conducted a retrospective cross-sectional study that included 48 patients with active acromegaly. The subjects were divided into two groups by the results of 75 g OGTT: normal glucose tolerance (NGT) group (n = 19) and IGT+ DM group (n = 29). Results: Systolic blood pressure (SBP) was significantly higher in the IGT+ DM than in the NGT group. Homeostasis model assessment of beta-cell function (HOMA-beta) was significantly decreased in the IGT+ DM group compared with the NGT group. Although serum GH or IGF-I levels were not different between the two groups, the IGF-I/GH ratio in the IGT+ DM group was significantly lower than that in the NGT group. Conclusions: We have shown that a low serum IGF-I/GH ratio was associated with abnormal glucose tolerance in acromegaly. We propose that the IGF-I/GH ratio is a useful marker to understand the metabolic status in acromegaly. Copyright (c) 2008 S. Karger AG, Basel.
引用
收藏
页码:165 / 171
页数:7
相关论文
共 50 条
  • [31] Acromegalic Cardiomyopathy: An Entity on its own? The Effects of GH and IGF-I Excess and Treatment on Cardiovascular Risk Factors
    Wolf, Peter
    Maione, Luigi
    Kamenicky, Peter
    Chanson, Philippe
    ARCHIVES OF MEDICAL RESEARCH, 2023, 54 (08)
  • [32] Random Gh and Igf-I levels after transsphenoidal surgery for acromegaly: relation with long-term remission
    Marcelo Lemos Vieira da Cunha
    Luis Alencar Biurrum Borba
    Cesar Luiz Boguszewski
    Endocrine, 2020, 68 : 182 - 191
  • [33] Dexamethasone decreases serum and liver IGF-I and maintains liver IGF-I mRNA in parenterally fed rats
    Kritsch, KR
    Murali, S
    Adamo, ML
    Ney, DM
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2002, 282 (02) : R528 - R536
  • [34] The action of GH/IGF-I/IGFBP in osteoblasts and osteoclasts
    Chihara, K
    Sugimoto, T
    HORMONE RESEARCH, 1997, 48 : 45 - 49
  • [35] Targeting either GH or IGF-I during somatostatin analogue treatment in patients with acromegaly: a randomized multicentre study
    Dal, Jakob
    Klose, Marianne
    Heck, Ansgar
    Andersen, Marianne
    Kistorp, Caroline
    Nielsen, Eigil H.
    Bollerslev, Jens
    Feldt-Rasmussen, Ulla
    Jorgensen, Jens O. L.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2018, 178 (01) : 65 - 74
  • [36] Emerging Role of the GH/IGF-I on Cardiometabolic Control
    Oliveira, Carla R. P.
    Meneguz-Moreno, Rafael A.
    Aguiar-Oliveira, Manuel H.
    Barreto-Filho, Jose A. S.
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2011, 97 (05) : 434 - 439
  • [37] IGF-I and GH: Potential use in gene doping
    Harridge, Stephen D. R.
    Velloso, Cristiana P.
    GROWTH HORMONE & IGF RESEARCH, 2009, 19 (04) : 378 - 382
  • [38] Mechanisms of putative IGF-I receptor resistance in active acromegaly
    Janssen, Joseph A. M. J. L.
    GROWTH HORMONE & IGF RESEARCH, 2020, 52
  • [39] Low IGF-I levels are often uncoupled with elevated GH levels in catabolic conditions
    Gianotti, L
    Broglio, F
    Aimaretti, G
    Arvat, E
    Colombo, S
    Di Summa, M
    Gallioli, G
    Pittoni, G
    Sardo, E
    Stella, M
    Zanello, M
    Miola, C
    Ghigo, E
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1998, 21 (02) : 115 - 121
  • [40] Low IGF-I levels are often uncoupled with elevated GH levels in catabolic conditions
    L. Gianotti
    F. Broglio
    G. Aimaretti
    E. Arvat
    S. Colombo
    M. Di Summa
    G. Gallioli
    G. Pittoni
    E. Sardo
    M. Stella
    M. Zanello
    C. Miola
    E. Ghigo
    Journal of Endocrinological Investigation, 1998, 21 : 115 - 121